| Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms JW Ko, N Sukhova, D Thacker, P Chen, DA Flockhart Drug metabolism and disposition 25 (7), 853-862, 1997 | 273 | 1997 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing JJ Lima, CD Thomas, J Barbarino, Z Desta, SL Van Driest, N El Rouby, ... Clinical Pharmacology & Therapeutics 109 (6), 1417-1423, 2021 | 215 | 2021 |
| A brief background on cannabis: From plant to medical indications LE Klumpers, DL Thacker Journal of AOAC International 102 (2), 412-420, 2019 | 125 | 2019 |
| In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms R Abbas, CP Chow, NJ Browder, D Thacker, SL Bramer, CJ Fu, W Forbes, ... Human & experimental toxicology 19 (3), 178-184, 2000 | 64 | 2000 |
| The flockhart cytochrome P450 drug-drug interaction table DA Flockhart, D Thacker, C McDonald, Z Desta Division of Clinical Pharmacology, Indiana University School of Medicine, 2021 | 47 | 2021 |
| Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone CB Trapnell, SR Donahue, JM Collins, DA Flockhart, D Thacker, ... Clinical Pharmacology & Therapeutics 64 (6), 597-602, 1998 | 29 | 1998 |
| Stereoselective pharmacokinetics of stable isotope (+/−)‐[13C]‐pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity DL Thacker, A Modak, PD Nguyen, DA Flockhart, Z Desta Chirality 23 (10), 904-909, 2011 | 28 | 2011 |
| Application of the quartz crystal microbalance to characterize the interaction of solutes with modified interfaces JA Roush, DL Thacker, MR Anderson Langmuir 10 (6), 1642-1646, 1994 | 19 | 1994 |
| Sensitive assay for pimozide in human plasma using high-performance liquid chromatography with fluorescence detection: application to pharmacokinetic studies T Kerbusch, Z Desta, NV Soukhova, D Thacker, DA Flockhart Journal of Chromatography B: Biomedical Sciences and Applications 694 (1 …, 1997 | 18 | 1997 |
| Is (+)-[13C]-pantoprazole better than (±)-[13C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity? DL Thacker, A Modak, DA Flockhart, Z Desta Journal of breath research 7 (1), 016001, 2012 | 14 | 2012 |
| Drug Interactions Flockhart Table™ DA Flockhart, D Thacker, C McDonald, Z Desta | 11 | 2018 |
| Cannabis dopaminergic effects induce hallucinations in a patient with Parkinson’s disease K Pizzolato, D Thacker, ND Toro-Pagán, A Hanna, J Turgeon, A Matos, ... Medicina 57 (10), 1107, 2021 | 5 | 2021 |
| Pharmacist-led medication evaluation considering pharmacogenomics and drug-induced phenoconversion in the treatment of multiple comorbidities: a case report NM Del Toro-Pagán, A Matos, D Thacker, J Turgeon, NS Amin, V Michaud Medicina 57 (9), 955, 2021 | 5 | 2021 |
| Identification and characterization of human cytchrome P450 (CYP) isoforms interacting with cisapride Z Desta, D Thacker, N Soukhova, JG Shin, DA Flockhart Clinical Pharmacology & Therapeutics 65 (2), 126-126, 1999 | 4 | 1999 |
| Metabolism of An Anabolic Androgenic Steroid Oxymetholone by Human Cytochrome P450s DL Thacker, I Wainer, C Lerch, K Fried, DA Flockhart Clinical Pharmacology & Therapeutics 65 (2), 136-136, 1999 | 3 | 1999 |
| Serum and brain levels of 5, 5-diphenylbarbituric acid (DPB) after administration of dimethoxymethyl-diphenyl-barbituric acid (T2000) in the rat A Raines, DA Flockhart, KL Dretchen, DL Thacker, A Sinzh, A Yacobi Epilepsia 37 (Suppl 6), 23, 1996 | 2 | 1996 |
| Bringing Pharmacogenetics to Prescribers: Progress and Challenges DL Thacker, J Savieo, H Hachad Advances in Molecular Pathology 3, 117-129, 2020 | 1 | 2020 |
| Indoleamine 2, 3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT TC Quigg, BD Pope, C Spiegel, DL Thacker, JD Robarge, TC Skaar, ... Biology of Blood and Marrow Transplantation 19 (2), S338-S339, 2013 | 1 | 2013 |
| CYTOCHROME P450 (CYP) 2C19 SPECIFIC BREATH TEST USING (+)-[13C]-PANTOPRAZOLE AS A PHENOTYPE PROBE. DL Thacker, AS Modak, SM Lemler, DA Flockhart, Z Desta CLINICAL PHARMACOLOGY & THERAPEUTICS 87, S51-S51, 2010 | 1 | 2010 |
| Method for the determination of 5, 5-diphenylbarbituric acid and its separation from 1, 3-dimethoxymethyl-5, 5-diphenylbarbituric acid in plasma by high-performance liquid … DL Thacker, DR Abernethy, A Raines, DA Flockhart Journal of Chromatography B: Biomedical Sciences and Applications 710 (1-2 …, 1998 | 1 | 1998 |
Flockhart DProfessor of Medicine, Indiana University School of MedicineVerified email at iupui.edu
